BABYLAT: A NEW DEVICE TO IMPROVE PRETERM NUTRITION
Our innovative device enriches macronutriental content of human milk onsite
The problem we solve
During the first months of life, a lack of macro-and micronutrients in preterm infant's diet causes growth delay (1). Human milk is the best nutrition for any neonate but for preterm neonates it can not cover their special daily needs in extra protein content. Nowadays to solve this problem the proteins of non-human origin (cow's milk proteins) are added into human milk to increase its protein value. Such fortified milk allows the child to get the necessary amount of nutrients, but this practice also carries a potential risk of side effects due to the non-human origin of the proteins (2). Additionally it prevents to keep 100% human milk-based diet, which is recommended by WHO to any neonate during first six months of live (3). The only way to solve this problem is to add to the human milk the human-milk origin proteins. With our novel device we hope we can provide an innovative solution for this well-known problem.
References:
1. Arslanoglu S, Boquien CY, King C, Lamireau D, Tonetto P, Barnett D, Bertino E, Gaya A, Gebauer C, Grovslien A, Moro GE, Weaver G, Wesolowska AM, Picaud JC. Fortification of Human Milk for Preterm Infants: Update and Recommendations of the European Milk Bank Association (EMBA) Working Group on Human Milk Fortification. Front Pediatr. 2019 Mar 22;7:76.
2. Melinda J. Elliott, Sergio G. Golombek; Evolution of Preterm Infant Nutrition from Breastfeeding to an Exclusive Human Milk Diet: A Review. Neoreviews August 2022; 23 (8): e558–e571.
3. https://www.who.int/health-topics/breastfeeding#ta...
References:
1. Arslanoglu S, Boquien CY, King C, Lamireau D, Tonetto P, Barnett D, Bertino E, Gaya A, Gebauer C, Grovslien A, Moro GE, Weaver G, Wesolowska AM, Picaud JC. Fortification of Human Milk for Preterm Infants: Update and Recommendations of the European Milk Bank Association (EMBA) Working Group on Human Milk Fortification. Front Pediatr. 2019 Mar 22;7:76.
2. Melinda J. Elliott, Sergio G. Golombek; Evolution of Preterm Infant Nutrition from Breastfeeding to an Exclusive Human Milk Diet: A Review. Neoreviews August 2022; 23 (8): e558–e571.
3. https://www.who.int/health-topics/breastfeeding#ta...
What is Babylat?
Babylat is the first automated tabletop device for human milk protein and fat enrichment. It is easy to use even without special medical training because all enrichment processes are automated and do not require additional laboratory equipment. After extraction, the enriched fraction is added to human milk to increase its protein and energy value without cow milk products. Babylat is a unique solution to help to feed the preterm neonates by most efficient way with own's mother milk or donor milk cause it allows to prepare human milk-origin fortifiers onsite
Our Benefits
TIME FOR ENRICHMENT
The enrichment process takes less than any known market-available solutions
No additives
Babylat device uses only human milk with no chemical additives. This feature minimizes the risk to the baby's health
Product variability
The ability to select a unique composition to meet the needs of each individual baby
On-site enrichment
Our device allows enrichment process to be performed at any interested hospital onsite
personalized nutrition
A unique option to use only mother's milk to create an enriched product
Low cost
Fewer steps to enrich human milk by our novel method significantly reduce production costs
Zero-km product
Novel fast protocol allows to keep the human milk -origin product to be as natural as possible and has less negative impact to CO2 emission (zero-logistic)
Ethically non-biased
We do not commercialize human milk and its derivatives and the origin of the human milk is controlled by health providers
About us
The company was founded in 2020 in Bern, Switzerland and during these years we have won several grants and awards, including the grant from Innosuisse, a leading national agency for innovation (grant number 100.060). Last year we also got the support from leading national angel investors community, BAS (Business Angels of Switzerland)
We are very grateful to all our sponsors for their generous support.
Currently we are searching for research collaborators willing to test our novel device, please be in contact with us.
Meet Our Team
The highly-dedicated team of professionals driven by wish to help to neonates
- Zina Yudina, PhDFounder and CEOExperience:
>15 years of experience with a profound knowledge in molecular biology and biochemistry
Roles:
Research, device development. fundraising, IP, clinicians communications - Florian PolesCTOExperience:
>15 years of experience in engineering
Roles:
Engineering, planning, risk analysis, time management - Thomas KerscherFinancials and Member of Board of DirectorsExperience:
>25 years of experience with a profound knowledge in Healthcare markets.
Roles:
Business planning, financials - Henrico DolfingNon-executive member of Board of Directors>20 years of experience as entrepreneur, investor, crisis manager, author of several books
Roles:
Project planning, investor relation, business strategy
Contact details:
If you have any questions – contact us!
E-Mail
info@babylat.com
Address
Babylat AG
Weyermannsstrasse 38
3006 Bern
Switzerland
Weyermannsstrasse 38
3006 Bern
Switzerland
We use cookies to provide the best site experience.
Trusted by:
If you are interested in becoming a partner or sponsor, please feel free to contact us.
